Scribd Logo
Upload

Welcome to Scribd!

  • Pitch Draft

    Uploaded by

    hamdajavaid786
    5 views18 pages
    Tomas Narbutas is seeking investors for his company OIR, which has developed an innovative thermal splint to treat wrist channel syndrome. The splint stimulates nerves and maintains the correct wrist position using nanoparticle fabric to provide warmth and massage. Clinical trials showed an 81% positive effect rate. OIR is seeking €450,000 over 24 months for product certification, marketing, and further clinical trials to expand sales internationally from its current 450 units per year. Financial projections estimate annual sales could reach 90,000 units in 5 years.

    Original Description:

    Copyright

    © © All Rights Reserved

    Available Formats

    PPTX, PDF, TXT or read online from Scribd

    Did you find this document useful?

    Is this content inappropriate?

    Report this Document
    Tomas Narbutas is seeking investors for his company OIR, which has developed an innovative thermal splint to treat wrist channel syndrome. The splint stimulates nerves and maintains the correct wrist position using nanoparticle fabric to provide warmth and massage. Clinical trials showed an 81% positive effect rate. OIR is seeking €450,000 over 24 months for product certification, marketing, and further clinical trials to expand sales internationally from its current 450 units per year. Financial projections estimate annual sales could reach 90,000 units in 5 years.

    Copyright:

    © All Rights Reserved
    Download as PPTX, PDF, TXT or read online from Scribd
    Flag for inappropriate content
    Download as pptx, pdf, or txt
    5 views18 pages

    Pitch Draft

    Uploaded by

    hamdajavaid786
    Tomas Narbutas is seeking investors for his company OIR, which has developed an innovative thermal splint to treat wrist channel syndrome. The splint stimulates nerves and maintains the correct wrist position using nanoparticle fabric to provide warmth and massage. Clinical trials showed an 81% positive effect rate. OIR is seeking €450,000 over 24 months for product certification, marketing, and further clinical trials to expand sales internationally from its current 450 units per year. Financial projections estimate annual sales could reach 90,000 units in 5 years.

    Copyright:

    © All Rights Reserved
    Download as PPTX, PDF, TXT or read online from Scribd
    Flag for inappropriate content
    Download as pptx, pdf, or txt
    of 18

    Kaip pristatyti savo verslą

    investuotojams?

    Source: Donatas Jonikas/Vita Veržukauskė


    OIR
    INNOVATIVE METHOD FOR THE TREATMENT OF WRIST CHANNEL SYNDROME

    CEO
    TOMAS NARBUTAS
    tomas@oir.com
    www.oir.com
    +370 612 532 21
    PROBLEM - constant numbness
    and pain in the wrist area
    Target audience - Women suffer more than men 7 times

    45% 25% 31% 12%


    47%

    40 +
    Solution Thermal splint "OIR" from nanoparticle fabric

    STIMULATES THE NERVE MAINTAINS THE RIGHT POSITION

    OIR
    WARM MASSAGE
    FUNCTIONALITY example of a working principle

    OIR
    PODUCT BENEFITS EFFICIENCY
    NAUDA

    NON - INVASIVE
    working capacity 84% TREATMENT

    affordable price
    positive result 97%

    Fast result

    Efficiency
    TEST - validation
    19% 14
    returnable products
    No effect

    86
    81% POSITIVE
    effect FEEDBACK

    17 POSITIVE
    Feedback from 180 clients, who have tested the productOIR
    FEEDBACK
    COMPETITORS ANALYSIS

    Product in Clinicaly
    market approved Price 50 EUR E-shop

    REPAIRABLE
    OPERATION

    OIR
    SPLINT

    MAGNETIC
    BRASLET

    ELECTRICAL
    STIMULATOR
    CANVAS MODEL

    VALUE PROPOSITION - ...


    BUSINESS MODEL

    Retail price Wholesale price


    149 Eur 109 Eur

    450 units
    10 000 units.per year
    Per year

    Partners
    Sales in Lithuania
    JAV, KINIJA

    Production in Production in China


    Ukraine
    PRODUCT DEVELOPMENT
    400K €
    100K € INVESTMENT
    INVESTMENT
    170K € CLINICAL
    MVP‘S SALES TRIALS
    CLINICAL
    TRIALS SERTIFIKATO
    GAVIMAS

    FIDN PRODUCT PRODUCT


    CUSTMERS ANALYTICS PRODUCT PATENT
    NEED FRO
    HOSPITALS
    TEAM Biomedical Engineer
    LINA RUTKAUSKIENĖ
    Marketing manager
    ADOMAS PAKALNIS

    7 years experience 7 years experience

    CEO Biomedical Engineer


    TOMAS NARBUTAS TITAS MAŽEIKA
    10 years experience in management, 5 years in product
    product development development

    TERMINUOTAI DIRBANTYS KOLEGOS dizaino specialistai, kineziterapeutai


    Funding needed for the -
    next 24 months PRODUCT SERTIFICATION

    20%

    5% MARKETING

    450K
    EXPENCES
    PRODUCTION
    50%
    Clinical trials
    ISO 13485
    CE Class 2a
    25% FDA
    FINANCIAL PROJECTIONS -market

    90 000 OIR

    40 000 OIR

    20 000 OIR Turnover


    Profit
    4200 OIR

    520 OIR
    Thank you for Your attention

    QUESTIONS?
    Gen. direktorius
    TOMAS NARBUTAS
    tomas@oir.com
    www.oir.com
    +370 612 532 21

    You might also like